SUPERNUS PHARMACEUTICALS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 27.54 USD | -1.36% |
|
+3.65% | -4.84% |
| May. 23 | Supernus Pharmaceuticals Reports 'Clinical Utility' From Epilepsy Treatment Study | MT |
| May. 23 | Transcript : Supernus Pharmaceuticals, Inc. - Special Call |
Quotes 5-day view
Delayed Quote Nasdaq| 2024-05-31 | 2024-06-03 | 2024-06-04 | 2024-06-05 | |
|---|---|---|---|---|
| Last | 27.12 $ | 27.61 $ | 27.92 $ | 27.54 $ |
| Volume | 527 138 | 481 959 | 471 699 | 486 947 |
| Change | +2.07% | +1.81% | +1.12% | -1.36% |
| Opening | 26.82 | 27.13 | 27.50 | 27.98 |
| High | 27.26 | 28.13 | 28.34 | 28.00 |
| Low | 26.42 | 26.42 | 27.33 | 27.18 |
Performance
| 1 day | -1.36% | ||
| 1 week | +3.65% | ||
| Current month | +1.55% | ||
| 1 month | -10.67% | ||
| 3 months | -9.26% | ||
| 6 months | -0.86% | ||
| Current year | -4.84% | ||
| 1 year | -18.23% | ||
| 3 years | -7.83% | ||
| 5 years | -11.08% | ||
| 10 years | +199.35% |
Volumes
marketsDaily volume
486 947
Estimated daily volume
486 947
Avg. Volume 20 sessions
625 220
Daily volume ratio
0.78
Avg. Volume 20 sessions USD
17 218 558.80
Record volume 1
11 208 680
Record volume 2
6 737 648
Record volume 3
6 644 855
Capital turnover ratio
0.01
Float rotation
0.01
Basic data
Capitalization (USD)
1 534 881 171
Net sales (USD)
607 521 000
Number of employees
652
Sales / Employee (USD)
931 781
Free-Float
94.98 %
Free-Float capitalization (USD)
1 457 829 872
Average Daily Capital Traded
1.12%
Highs and lows
1 week
26.42
28.34
1 month
26.1232.87
Current year
26.1235.44
1 year
21.9935.96
3 years
21.9942.09
5 years
13.1242.09
10 years
7.3161.25
Indicators
Moving average 5 days
27.16
Moving average 20 days
28.62
Moving average 50 days
30.25
Moving average 100 days
29.94
Price spread / (MMA5)
-1.39%
Price spread / (MMA20)
+3.92%
Price spread / (MMA50)
+9.84%
Price spread / (MMA100)
+8.72%
STIM
RSI 9 days
42.43
RSI 14 days
40.55
Sector Comparison - Specialty & Advanced Pharmaceuticals
| Name | Change | 5d. change | 1st Jan change | 1-year change | Capi. | |
|---|---|---|---|---|---|---|
| -1.36% | +3.65% | -4.84% | -18.23% | 1.53B | ||
| +2.65% | +1.34% | +18.49% | +1.43% | 78.7B | ||
| -0.15% | +5.67% | +14.09% | -1.89% | 9.26B | ||
| -1.39% | +3.15% | -15.14% | +14.67% | 4.92B | ||
| -2.30% | -6.96% | +45.17% | +102.66% | 4.66B | ||
| +1.40% | +14.20% | +15.70% | +37.24% | 4.27B | ||
| -2.47% | -1.91% | +16.71% | -13.02% | 2.44B | ||
| -0.78% | -0.94% | -26.13% | -29.59% | 2.22B | ||
| -2.24% | +0.98% | +15.73% | -8.26% | 2.15B | ||
| -1.57% | -5.12% | -40.52% | -50.97% | 1.89B | ||
| -.--% | -.--% | - | - | 1.64B | ||
| +0.24% | -1.51% | -4.69% | -6.65% | 1.16B | ||
| +2.50% | +4.35% | -13.66% | -34.44% | 1.09B | ||
| +0.10% | +2.26% | +63.49% | +125.87% | 1.07B | ||
| +2.19% | +23.43% | +62.26% | +54.55% | 1.02B | ||
| -1.10% | +4.12% | +2.27% | +8.48% | 912M | ||
| Average | -0.27% | +2.46% | +9.93% | +12.12% | ||
| Weighted average by Cap. | +1.53% | +0.34% | +15.64% | +6.12% |
Historical data
| Date | Opening | High | Low | End-of-day | Volume |
|---|
Last transactions
6dc6486022496be664ad1a1.liwCHfiQaC0gz8MK_85criAJy4JEtJ07Q16Wy95nOrQ.w0FkUZz-Xmh6_vZwjZ4l1EtDrbsT1dBJDQz78qoGaPjidnRRnMgBSH-F-w
| Date | Price | Volume | Daily volume |
|---|---|---|---|
| 04:00:00 pm | 27.54 | 59,495 | 335,781 |
| 03:59:59 pm | 27.57 | 271 | 276,286 |
| 03:59:58 pm | 27.54 | 100 | 276,015 |
| 03:59:58 pm | 27.54 | 100 | 275,915 |
| 03:59:55 pm | 27.54 | 100 | 275,815 |
| 03:59:55 pm | 27.54 | 100 | 275,715 |
| 03:59:55 pm | 27.54 | 100 | 275,615 |
| 03:59:55 pm | 27.54 | 127 | 275,515 |
| 03:59:55 pm | 27.55 | 100 | 275,388 |
| 03:59:53 pm | 27.56 | 100 | 275,288 |
Monthly variations
Annual change
| 2024 | -4.84% | ||
| 2023 | -18.87% | ||
| 2022 | +22.33% | ||
| 2021 | +15.90% | ||
| 2020 | +6.07% | ||
| 2019 | -28.60% | ||
| 2018 | -16.64% | ||
| 2017 | +57.82% | ||
| 2016 | +87.87% | ||
| 2015 | +61.93% | ||
| 2014 | +10.08% | ||
| 2013 | +5.16% | ||
| 2012 | +33.52% |
- Stock Market
- Equities
- SUPN Stock
- Quotes Supernus Pharmaceuticals, Inc.
